HC Wainwright Reaffirms "Buy" Rating for Tyra Biosciences (NASDAQ:TYRA)
HC Wainwright reiterated their buy rating on shares of Tyra Biosciences (NASDAQ:TYRA – Get Rating) in a report published on Thursday, Benzinga reports. The brokerage currently has a $17.00 price target on the stock. HC Wainwright also issued estimates for Tyra Biosciences’ Q1 2024 earnings at ($0.40) EPS, Q2 2024 earnings at ($0.44) EPS, Q3 […]